Escors Murugarren ,
‘Our goal: finding a cure for cancer’
Head of the Unit
Study of two barriers in melanoma immunotherapy: Myeloid derived suppressor cells and PDL1/PD1 interaction.
Molecular Tuning of Telomerase Activity in Senescent Human T cells.
Plasma membrane dynamics regulating the PD-1: PD-L1 pathway.
Lentivector-based cancer immunotherapy silencing PD-L1 and modulating cytokine priming; Development of ex vivo myeloid-derived suppressor cells to assess therapeutic efficacy.
Understanding the mechanisms of NF-kB activation by viral oncoproteins vFLIP and Tax.
Innate Immune Recognition of Glycosylated Surface Determinants of Campylobacter jejuni.